Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02003651 · ClinicalTrials.gov registry record · NA
Echinacea and Acute Respiratory Illness
A NA study, sponsored by Appalachian State University.
- Completed
- Registry status
- NA
- Development phase
- 40
- Enrollment target
NCT02003651 is a NA study that has completed, run by Appalachian State University. The registered enrollment target is 40 participants.
The verdict
NCT02003651, a NA study, has completed, sponsored by Appalachian State University.
- COMPLETED
- Registry status
- NA
- Development phase
- 40 participants
- Enrollment target
Study Summary
The primary objective of this study is to evaluate the effectiveness of ingesting an alkylamide-rich echinacea root product (Quick Defense, Gaia Herbs) for 2 days immediately following each onset of acute respiratory illness (ARI) symptomatology during a 12-week period in the winter and early spring in women. Hypothesis: Subjects randomized to Quick Defense compared to placebo over a 12-week period will experience reduced ARI symptomatology, both acutely during each ARI episode and collectively over the entire 12-week study period.
Interventions
- DIETARY_SUPPLEMENT Placebo
- DIETARY_SUPPLEMENT Quick Defense
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 40 participants |
| Start Date | 2013-11 |
| Est. Completion | 2014-08 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02003651
The ClinicalTrials.gov registry entry for NCT02003651 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 40 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Appalachian State University, which has 37 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Placebo is the first listed.
NCT02003651 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02003651 about?
NCT02003651 is a clinical study titled "Echinacea and Acute Respiratory Illness". The primary objective of this study is to evaluate the effectiveness of ingesting an alkylamide-rich echinacea root product (Quick Defense, Gaia Herbs) for 2 days immediately following each onset of acute respiratory illness (ARI) symptomatology during a 12-week period in the winter and early spring...
What is the current status of trial NCT02003651?
This trial is currently completed. It is a NA study. The enrollment target is 40 participants. The study started on 2013-11. Estimated completion is 2014-08.
What interventions are being tested in trial NCT02003651?
The interventions under investigation include: Placebo (DIETARY_SUPPLEMENT), Quick Defense (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT02003651?
This trial is sponsored by Appalachian State University, which has 37 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.